GlobeNewswire

Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care
11/11/2026
Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World Diabetes Day (14 November), the funding will [...]
Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management
11/11/2026
After a year of building with manufacturing and quality teams, Devia spins out of Visium and is now available to the world’s largest biopharma companies, CDMOs and CROs, so every deviation gets solved once, not closed [...]
Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London
11/11/2026
Leiden, the Netherlands, November 11, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the 2026 Jefferies Global Healthcare Conference in London, United Kingdom, on November [...]
Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie
11/11/2026
VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Onco-Innovations Limited (CBOE: ONCO ) (“ Onco ” or the “ Company ”) announces that it has entered into a termination agreement (the “ Termination Agreement [...]
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
11/11/2026
MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18, [...]
Prime Medicine Announces Pricing of Public Offering of Common Stock
11/11/2026
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies
11/11/2026
SYDNEY, AUSTRALIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new [...]
U.S. News & World Report Names Over 100 Independently Operating Ensign Group Affiliates Among Best Nursing Homes for 2027
11/11/2026
SAN JUAN CAPISTRANO, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), which invests in facilities that provide skilled nursing and senior living services, physical, occupational and [...]
Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers
10/11/2026
Recognition marks second consecutive year Amneal has been named a BioSpace Best Place to Work BRIDGEWATER, N.J., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) [...]
Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates
10/11/2026
ST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial [...]
Kura Oncology Reports Third Quarter 2026 Financial Results and Corporate Update
10/11/2026
– KOMZIFTI ® (ziftomenib) net product revenue grew 53% sequentially to $13.9 million; new patient starts increased 30% and total prescriptions grew 65% – – KOMZIFTI maintained majority share of new patient starts of the [...]
Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London
10/11/2026
Mechelen, Belgium; November 10, 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the 2026 Jefferies Global Healthcare Conference [...]
Inhibikase Therapeutics Announces Third Quarter 2026 Financial Results and Highlights Recent Activity
10/11/2026
WILMINGTON, Del., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Freenome Reports Third Quarter 2026 Financial Results
10/11/2026
– Third-quarter results reflect revenue of $183.5 million driven by the FDA approval of SimpleScreen™ CRC – – Entered the public market and raised gross proceeds of $310 million – BRISBANE, Calif., Nov. 10, 2026 (GLOBE [...]
Ascendis Pharma to Participate in the Jefferies London Healthcare Conference
10/11/2026
COPENHAGEN, Denmark, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Jefferies London Healthcare Conference on [...]
Stereotaxis Announces Convertible Note Financing of Up To $24 Million
10/11/2026
ST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has entered into [...]
Eupraxia Pharmaceuticals Reports Third Quarter 2026 Financial Results
10/11/2026
Reached target enrollment of 120 patients in the Phase 2b placebo-controlled blinded portion of the RESOLVE trial evaluating EP-104GI for Eosinophilic Esophagitis (EoE) Phase 2b interim analysis expected in December [...]
Immutep Announces Release of CTOS 2026 Abstract Reporting First Survival Data from EFTISARC-NEO
11/11/2026
First survival data from EFTISARC-NEO, released in CTOS 2026 Abstract, demonstrate encouraging preliminary long-term outcomes in patients with resectable soft tissue sarcoma (STS). With a median follow-up of 19.1 months [...]
Fibermaxxing Hits the Holiday Table: Brenda Watson’s 7 Ways to Make Stuffing Healthier
11/11/2026
TAMPA, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- The viral “fibermaxxing” trend is making its way to the holiday table, and digestive health expert and New York Times bestselling author Brenda Watson says traditional [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum